Greater Cannabis Company (GCAN) Operating Income Growth (1y) (2018 - 2026)
Greater Cannabis Company (GCAN) Operating Income Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.33 Bn | 87.46 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.12 Bn | 20.96 Bn | 648.10 Mn | -14.89% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 21.25% |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | 23.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.34% |
| Dec 31, 2025 | -43.01% |
| Sep 30, 2025 | 7.49% |
| Jun 30, 2025 | -22.91% |
| Mar 31, 2025 | -11.77% |
| Dec 31, 2024 | 14.54% |
| Sep 30, 2024 | 19.86% |
| Jun 30, 2024 | 5.19% |
| Mar 31, 2024 | 1.31% |
| Dec 31, 2023 | -4.16% |
| Sep 30, 2023 | -2.35% |
| Jun 30, 2023 | 3.79% |
| Mar 31, 2023 | 6.98% |
| Dec 31, 2022 | 64.81% |
| Sep 30, 2022 | 33.68% |
| Jun 30, 2022 | 31.12% |
| Mar 31, 2022 | 50.80% |
| Dec 31, 2021 | -124.36% |
| Sep 30, 2021 | -4.81% |
| Jun 30, 2021 | 23.72% |